Barry Coller
Barry Coller · Science & Medicine
Hematologist whose research led to the anti-platelet drug abciximab
1945, Queens, New York, United States
United States
Barry Coller is recognized among Jewish contributors to Science & Medicine — Hematologist whose research led to the anti-platelet drug abciximab
Barry Coller is a hematologist whose research on the platelet GPIIb/IIIa receptor led to the development of the anti-platelet drug abciximab, used to prevent clotting in patients undergoing coronary procedures. He became physician-in-chief of Rockefeller University Hospital and a member of the National Academy of Sciences. He was born to a Jewish family in Queens, New York.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biomedical Science
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Hematologist whose research led to the anti-platelet drug abciximab
Source: Jinfo.org — Jews in Biomedical Science
Similar Contributors
Ján Vilček
Harvey Weiss
Bernard Brodie
Bernard G. Sarnat
Bryan Mendelson
